v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 58,351 $ 113,084
Cost of goods sold 1,183,207 219,792
Gross loss (1,124,856) (106,708)
Operating expenses:    
Research and development 760,417 2,129,990
Sales and marketing 268,355 718,092
General and administrative 3,062,326 2,843,317
Total operating expenses 4,091,098 5,691,399
Loss from operations (5,215,954) (5,798,107)
Other income (expense):    
Other income, net 61,698
Interest income 153,298 144,360
Change in fair value - warrant liability 1,072,800
Change in fair value - derivative liability 9,000
Unrealized gain (loss) on marketable securities (35,019) 51,280
Realized gain on marketable securities 377,123 65,000
Other income (expense), net 1,577,202 322,338
Net loss (3,638,752) (5,475,769)
Preferred stock dividends (452,086)
Accretion of discounts to redemption value of Series H-7 Convertible Preferred Stock (3,095,473)
Net loss attributable to common stockholders $ (7,186,311) $ (5,475,769)
Net loss per share, basic $ (1.46) $ (1.17)
Net loss per share, diluted $ (1.46) $ (1.17)
Weighted average common stock outstanding, basic 4,929,490 4,664,988
Weighted average common stock outstanding, diluted 4,929,490 4,664,988

Source